David Einhorn's position in Gain Therapeutics is currently worth $777 Thousand. That's 0.04% of their equity portfolio (35th largest holding). The investor owns 2.28% of the outstanding Gain Therapeutics stock. The investor's estimated purchase price is $7.33 Million, resulting in a loss of 89%.